• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

589例分化型甲状腺癌患者术后局部复发或远处转移判别函数的诱导

Induction of discriminant function concerning postoperative local recurrence or distant metastasis in 589 patients with differentiated thyroid cancer.

作者信息

Mori Y, Takaya K, Miyata Y, Satomi S, Sasaki T, Taguti Y, Mori S, Sekita Y, Matoba N, Kurihara H

机构信息

Second Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Surg Today. 1993;23(9):777-85. doi: 10.1007/BF00311619.

DOI:10.1007/BF00311619
PMID:8219610
Abstract

For the purpose of predicting postoperative local recurrence and/or distant metastasis in differentiated thyroid cancer, a discriminant analysis was done. To assess the reliability of this method and the induced function, simulation was done by using random samples under various conditions. Simulation revealed that the results obtained by this method were relatively stable. The discriminant functions Z1 and Z2 were induced, which are required at many hospitals. If the ratio of recurrence is less than 1:8 in a hospital, function Z1 should be applied. If the ratio is 1:10, function Z2 should be applied. Z1 = -(sex x 2.104) + (age x 0.032) - (diameter of tumor x 0.033)-(site of tumor x 0.871) - (histology x 0.393) + 0.249 (discriminant boundary 0.451) Z2 = -(sex x 1.967) + (age x 0.018) + (diameter of tumor x 0.025) - (site of tumor x 0.646) + (histology x 0.014) - (local invasion x 0.840) - (lymph node metastasis x 0.009) + (operation x 0.364) - (lymph node dissection x 0.235) + 1.058 (discriminant boundary 0.400). In an internal check, sensitivity was 78%, specificity 64%; and false-negative rate 5%. In an external check, sensitivity was 68%, specificity 93%, and false-negative rate 9%. In the actual application to hospitals, sensitivity was 58% to 100%, specificity 47% to 63%, and false-negative rate 0% to 16%. In clinical usage, a high sensitivity and low false-negative rate are required. These results fulfilled this condition.

摘要

为了预测分化型甲状腺癌术后局部复发和/或远处转移,进行了判别分析。为评估该方法及其导出函数的可靠性,在各种条件下使用随机样本进行了模拟。模拟结果显示该方法所得结果相对稳定。导出了判别函数Z1和Z2,许多医院都需要使用。若某医院复发率小于1:8,则应使用函数Z1。若复发率为1:10,则应使用函数Z2。Z1 = -(性别×2.104)+(年龄×0.032)-(肿瘤直径×0.033)-(肿瘤部位×0.871)-(组织学类型×0.393)+0.249(判别边界0.451);Z2 = -(性别×1.967)+(年龄×0.018)+(肿瘤直径×0.025)-(肿瘤部位×0.646)+(组织学类型×0.014)-(局部侵犯×0.840)-(淋巴结转移×0.009)+(手术方式×0.364)-(淋巴结清扫×0.235)+1.058(判别边界0.400)。内部检验中,灵敏度为78%,特异度为64%,假阴性率为5%。外部检验中,灵敏度为68%,特异度为93%,假阴性率为9%。在医院实际应用中,灵敏度为58%至100%,特异度为47%至63%,假阴性率为0%至16%。在临床应用中,需要高灵敏度和低假阴性率。这些结果满足了这一条件。

相似文献

1
Induction of discriminant function concerning postoperative local recurrence or distant metastasis in 589 patients with differentiated thyroid cancer.589例分化型甲状腺癌患者术后局部复发或远处转移判别函数的诱导
Surg Today. 1993;23(9):777-85. doi: 10.1007/BF00311619.
2
Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.小儿分化型甲状腺癌的复发因素及并发症预防
Asian J Surg. 2017 Jan;40(1):55-60. doi: 10.1016/j.asjsur.2016.09.001. Epub 2016 Sep 30.
3
[Is total thyroidectomy and lymph node excision as therapy of differentiated thyroid gland carcinomas in childhood justified?].[全甲状腺切除术及淋巴结切除术作为儿童分化型甲状腺癌的治疗方法是否合理?]
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:196-8.
4
[Lymph node dissection in non-medullary differentiated thyroid carcinoma].[非髓样分化型甲状腺癌的淋巴结清扫术]
Ann Chir. 2006 Jul-Aug;131(6-7):361-8. doi: 10.1016/j.anchir.2005.10.009. Epub 2005 Nov 9.
5
Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.家族性非髓样甲状腺癌——临床相关性和预后。一项欧洲多中心研究。ESES 维也纳报告。
Langenbecks Arch Surg. 2010 Sep;395(7):851-8. doi: 10.1007/s00423-010-0696-0. Epub 2010 Aug 5.
6
Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas.与滤泡性和乳头状T4甲状腺癌相比,甲状腺岛状癌的预后较差,长期生存率较低。
Langenbecks Arch Surg. 2007 Nov;392(6):671-7. doi: 10.1007/s00423-006-0122-9. Epub 2007 Jan 10.
7
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
8
[Indication and extent of cervical lymph node dissection in differentiated thyroid carcinoma].[分化型甲状腺癌颈淋巴结清扫的指征及范围]
Zentralbl Chir. 2011 Aug;136(4):364-73. doi: 10.1055/s-0030-1247462. Epub 2010 Aug 13.
9
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.
10
Occult lymph node metastases increase locoregional recurrence in differentiated thyroid carcinoma.
Ann Otol Rhinol Laryngol. 2012 May;121(5):283-90. doi: 10.1177/000348941212100501.

本文引用的文献

1
FOLLOW-UP STUDY OF THYROID CANCER TREATED BY UNILATERAL LOBECTOMY.单侧甲状腺叶切除术治疗甲状腺癌的随访研究
Am J Surg. 1963 Sep;106:494-500. doi: 10.1016/0002-9610(63)90136-3.
2
Multicentricity of papillary adenocarcinoma of the thyroid: influence on treatment.甲状腺乳头状腺癌的多中心性:对治疗的影响。
J Clin Endocrinol Metab. 1960 Jan;20:130-5. doi: 10.1210/jcem-20-1-130.
3
Thyroid cancer: some basic considerations.甲状腺癌:一些基本考量
Am J Surg. 1981 Oct;142(4):474-9. doi: 10.1016/0002-9610(81)90378-0.
4
Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.甲状腺乳头状癌:576例患者治疗效果的10年随访报告
Am J Med. 1981 Mar;70(3):511-8. doi: 10.1016/0002-9343(81)90573-8.
5
Changing end results in patients with papillary carcinoma of the thyroid.甲状腺乳头状癌患者的最终结局变化
Surg Gynecol Obstet. 1971 Mar;132(3):460-8.
6
Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment.甲状腺乳头状癌。初次手术治疗后甲状腺复发。
Am J Surg. 1972 Oct;124(4):468-72. doi: 10.1016/0002-9610(72)90068-2.
7
Is the differentiation between papillary and follicular thyroid carcinoma valid?
Cancer. 1973 Oct;32(4):853-64. doi: 10.1002/1097-0142(197310)32:4<853::aid-cncr2820320417>3.0.co;2-2.
8
Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.
Cancer. 1986 Apr 1;57(7):1405-14. doi: 10.1002/1097-0142(19860401)57:7<1405::aid-cncr2820570728>3.0.co;2-o.
9
Prognosis in thyroid carcinoma.甲状腺癌的预后
Cancer. 1975 Sep;36(3):1138-46. doi: 10.1002/1097-0142(197509)36:3<1138::aid-cncr2820360346>3.0.co;2-8.
10
Prognostic features of thyroid cancer. A long-term followup of 68 cases.
Cancer. 1975 Aug;36(2):553-9. doi: 10.1002/1097-0142(197508)36:2<553::aid-cncr2820360234>3.0.co;2-#.